IDH2 and chondrosarcoma: Central chondrosarcomas carry mutations in the genes encoding the enzymes isocitrate dehydrogenase 1 or -2 (IDH1 or IDH2) [7–9] in approximately 50% of cases, resulting in production of the oncometabolite d-2-hydroxyglutarate (D-2HG).